On August 20, 2025, the United Kingdom’s Advertising Standards Authority (ASA) made headlines by banning a television advertisement for Sanex shower gel, a product owned by the global personal-care giant Colgate-Palmolive. The ad, which first aired in June 2025, quickly became a lightning rod for debate about racial sensitivity and the responsibilities of advertisers in a diverse society.
The controversy began when two viewers filed formal complaints with the ASA. Their concern? That the commercial’s narrative and imagery reinforced negative stereotypes about people with darker skin. According to CNN, the ad featured two Black individuals—one with red scratch marks and another with a surface resembling cracked clay—depicted as suffering from dry, itchy, and uncomfortable skin. In contrast, a White woman was shown with smooth, healthy skin after using Sanex Skin Therapy shower gel, which boasts a patented amino acid complex and claims certification by the British Skin Foundation.
The voiceover in the ad promised, “Relief can be as simple as a shower,” and highlighted the product’s ability to provide moisture for 24 hours. The message intended to showcase the effectiveness of Sanex’s formula, but the juxtaposition of skin tones and conditions struck a nerve. As the ASA explained in its official statement, “It was black skin, depicted in connection with itching and dryness, that was shown as problematic and uncomfortable, whereas white skin, depicted as smoother and cleaner after using the product, was shown as successfully changed and resolved.” The regulator concluded, “This could be interpreted as implying that white skin is superior to black.”
Colgate-Palmolive, for its part, pushed back against the criticism. The company emphasized that the use of diverse models was a deliberate decision meant to reflect its commitment to inclusivity. In a statement to BBC News, the brand said, “We take note of the ASA Council’s ruling. Our advert was intended to highlight how our Skin Therapy range supports healthy skin across a variety of skin types.” The company further noted, “At Sanex, our mission is to champion skin health for all, which is portrayed across our brand communications.”
Clearcast, the independent body responsible for vetting TV ads before they air in the UK, also weighed in. According to the ASA’s public findings, Clearcast maintained that the commercial demonstrated a “before and after” scenario to illustrate the product’s effectiveness for all skin types, not to draw a comparison based on race or ethnicity. Their perspective was that the ad’s structure was intended to reassure viewers that Sanex is suitable for everyone, regardless of skin color.
Despite these defenses, the ASA’s ruling was unequivocal. The authority acknowledged that while Colgate-Palmolive’s intent may not have been malicious, the narrative structure of the ad was problematic. By associating Black skin with discomfort and White skin with relief, the commercial risked perpetuating harmful stereotypes and violating the UK’s television and radio advertising code. The ban, the ASA stated, was necessary to “ensure it avoided causing serious offence on the grounds of race.”
The Sanex controversy has emerged amid a broader reckoning within the advertising industry in 2025. As reported by afaqs, ad-makers have faced a string of public backlashes over issues of cultural appropriation, body image, and racial representation. Earlier this year, Prada was criticized for its Kolhapuri ‘Sandals’ campaign, American Eagle’s ad featuring Sydney Sweeney drew both praise and criticism for its portrayal of genetics, and fashion giants Zara and Marks & Spencer saw their ads pulled for promoting unhealthy body images. Against this backdrop, the Sanex case highlights the increasing scrutiny on how brands navigate the complex terrain of diversity and inclusion.
Sanex, a Spanish personal-care brand known for its shower gels, moisturizers, deodorants, and soaps, has historically positioned itself as a champion of skin health for all. Its products, imported to India and priced between Rs 500 and Rs 5,000, are marketed as scientifically formulated and dermatologist-approved. The company’s advertising often emphasizes skin science and health, but as recent events show, even well-intentioned campaigns can stumble in their execution.
The ASA’s decision underscores a growing awareness among regulators and the public alike about the power of advertising to shape perceptions—sometimes in ways that are subtle but deeply impactful. The authority’s ruling noted that the ad “likely violated the television and radio advertising code and could have caused significant outrage.” It also sent a clear message to the advertising sector: inclusivity in casting is not enough if the narrative structure reinforces outdated or harmful ideas.
This episode has prompted many brands and agencies to revisit their creative processes. According to industry observers cited by CNN and afaqs, there is now a heightened emphasis on testing concepts and scripts with diverse focus groups before greenlighting campaigns. The goal is to ensure that well-meaning efforts to reflect diversity do not inadvertently reinforce negative stereotypes or create images that provoke outrage. As the ASA put it, it’s not just about who appears in an ad, but how they are portrayed and in what context.
Interestingly, the controversy also unearthed memories of a previous Sanex campaign from 15 years ago. As afaqs reported, that ad—designed to promote Sanex Dermo Active 3 Deodorant—featured a crowd of nude people sniffing each other’s armpits, a concept that many now view as tone-deaf and out of step with today’s sensitivities. This historical footnote serves as a reminder that the standards for what is considered acceptable in advertising are constantly evolving, often in response to changing social norms and consumer expectations.
For Colgate-Palmolive and the wider industry, the lesson is clear: intentions matter, but outcomes matter more. As brands strive to reflect the diversity of their customers, they must also take care to avoid narratives that, however unintentionally, perpetuate old prejudices or suggest that one group’s experience is the norm. The Sanex ban is not just about a single ad—it’s a signal that the bar for responsible, sensitive advertising is rising, and that brands ignore this shift at their peril.
The debate sparked by the Sanex commercial will likely echo for some time in boardrooms and creative studios alike. For now, the ASA’s ruling stands as a stark reminder that in today’s media landscape, every frame and every word carries weight—and that the quest for inclusivity must be matched by a commitment to thoughtful storytelling.